Missed OPPORTUNITY: growth hormone therapy in adults with CKD

The results of the largest, double-blind, placebo-controlled, multicentre, multinational randomized clinical trial (RCT) evaluating the effects of human growth hormone (hGH) on clinical outcome in 695 haemodialysed adults are published in this issue [1]. Designed to answer the important question whether hGH therapy might improve the notoriously poor survival in patients on dialysis, the OPPORTUNITY trial will enter the collective memory of the...